Tata Chemicals

  • Market Cap: Small Cap
  • Industry: Commodity Chemicals
  • ISIN: INE092A01019
  • NSEID: TATACHEM
  • BSEID: 500770
INR
727.60
-2.6 (-0.36%)
BSENSE

Jun 24, 03:30 PM

BSE+NSE Vol: 2.65 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

2.65 lacs (-40.57%) Volume

Shareholding (Mar 2026)

FII

11.90%

Held by 156 FIIs

DII

22.87%

Held by 31 DIIs

Promoter

37.98%

Why is Tata Chemicals Ltd. falling/rising?

24-Jun-2026

As of 23-Jun, Tata Chemicals Ltd. is facing a decline in its stock price, currently at 730.20, due to significant underperformance and negative financial results, including an 88.7% drop in profits over the past year. Weak growth metrics and high debt levels further exacerbate the negative market sentiment surrounding the company.

As of 23-Jun, Tata Chemicals Ltd. is experiencing a decline in its stock price, currently at 730.20, which reflects a change of -3.05 (-0.42%). This downward movement can be attributed to several factors highlighted in the provided data. <BR><BR>Firstly, the stock has shown a significant underperformance over various time periods, with a year-to-date decline of -4.60% and a one-year drop of -19.27%. This consistent underperformance is further emphasized by the company's negative financial results, including a staggering -88.7% decrease in profits over the past year and a -1939.44% fall in profit before tax (PBT) reported in March. Additionally, the company has declared negative results for the last two consecutive quarters, with a reported loss of Rs -295.00 crore, marking a -476.5% decline compared to the previous four-quarter average.<BR><BR>Moreover, Tata Chemicals Ltd. has weak long-term fundamental strength, evidenced by a -4.01% compound annual growth rate (CAGR) in operating profits over the last five years and a low return on equity (ROE) of 5.13%. The company's high debt-equity ratio of 0.38 times also raises concerns about its financial stability.<BR><BR>While there has been a slight increase in investor participation, with delivery volume rising by 11.05% against the five-day average, this has not been sufficient to counterbalance the negative sentiment surrounding the stock. The overall performance of the diversified sector, which has fallen by -3.66%, further compounds the challenges faced by Tata Chemicals Ltd.<BR><BR>In summary, the combination of poor financial performance, weak growth metrics, and negative market sentiment has contributed to the decline in Tata Chemicals Ltd.'s stock price.

View full answer

How big is Tata Chemicals?

11-Jun-2026

As of 10th June, Tata Chemicals Ltd. has a market capitalization of 19,211.00 Cr and reported net sales of 14,584.00 Cr with a net loss of 1,896.00 Cr over the latest four quarters.

As of 10th June, Tata Chemicals Ltd. has a market capitalization of 19,211.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, Tata Chemicals reported net sales of 14,584.00 Cr. However, the company experienced a net loss of 1,896.00 Cr during the same period.<BR><BR>The latest annual reporting period for Tata Chemicals is March 2026. At that time, the company had shareholder's funds amounting to 21,206.00 Cr and total assets of 38,998.00 Cr.

View full answer

Who are in the management team of Tata Chemicals?

11-Jun-2026

The management team of Tata Chemicals includes R Mukundan (Managing Director & CEO), Rajiv Chandan (Company Secretary), and several independent directors, with N Chandrasekaran serving as the Non-Executive Chairman and Ratan N Tata as Chairman Emeritus. This team combines extensive experience and expertise in the industry.

The management team of Tata Chemicals includes the following key individuals:<BR><BR>1. **Rajiv Chandan** - Company Secretary & Compliance Officer<BR>2. **R Mukundan** - Managing Director & CEO<BR>3. **Vibha Paul Rishi** - Independent Director<BR>4. **S Padmanabhan** - Director<BR>5. **Ratan N Tata** - Chairman Emeritus<BR>6. **Padmini Khare Kaicker** - Independent Director<BR>7. **Zarir Langrana** - Executive Director<BR>8. **C V Natraj** - Independent Director<BR>9. **K B S Anand** - Independent Director<BR>10. **N Chandrasekaran** - Chairman (Non-Executive)<BR>11. **Rajiv Dube** - Independent Director<BR><BR>This diverse team brings a wealth of experience and expertise to the company.

View full answer

Who are the peers of the Tata Chemicals?

11-Jun-2026

Tata Chemicals' peers include India Glycols, Gujarat Alkalies, GHCL, Tanfac Inds., Chemplast Sanmar, and others. Tanfac Inds. shows the highest growth and return, while Chemplast Sanmar has the lowest performance metrics.

Peers: The peers of Tata Chemicals are India Glycols, Gujarat Alkalies, GHCL, Tanfac Inds., Grauer & Weil, Chemplast Sanmar, Fischer Medical, Thirumalai Chem., and J.G.Chemicals.<BR><BR>Quality Snapshot: Excellent management risk is observed at GHCL and Chemplast Sanmar, while Average management risk is found at Tata Chemicals, India Glycols, Tanfac Inds., Grauer & Weil, Thirumalai Chem., and J.G.Chemicals, and Below Average management risk is noted at Fischer Medical. Growth is Good at Tanfac Inds. and J.G.Chemicals, while Average growth is seen at Tata Chemicals, India Glycols, Gujarat Alkalies, GHCL, Grauer & Weil, Thirumalai Chem., and the rest, and Below Average growth is noted at Chemplast Sanmar and Fischer Medical. Capital Structure is Excellent at Gujarat Alkalies, GHCL, Tanfac Inds., Grauer & Weil, and J.G.Chemicals, while Average capital structure is found at Tata Chemicals, and Below Average capital structure is observed at India Glycols, Chemplast Sanmar, Fischer Medical, Thirumalai Chem.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Tanfac Inds. at 20.10%, while the lowest is Chemplast Sanmar at -54.66%, with Tata Chemicals having a 1-year return of -22.71%, which is better than Chemplast Sanmar but worse than Tanfac Inds. Additionally, the six-month return is negative for GHCL, Chemplast Sanmar, Fischer Medical, Thirumalai Chem.

View full answer

Should I buy, sell or hold Tata Chemicals Ltd.?

10-Jun-2026

What does Tata Chemicals do?

10-Jun-2026

Tata Chemicals Ltd. is a small-cap company in the commodity chemicals industry, focusing on sustainable chemistry solutions. As of March 2026, it reported net sales of ₹3,438 Cr and a net loss of ₹2,132 Cr, with a market cap of ₹19,211 Cr.

Overview:<BR>Tata Chemicals Ltd. is a science-led sustainable chemistry solutions company operating in the commodity chemicals industry and classified as a small-cap entity.<BR><BR>History:<BR>Tata Chemicals Ltd. was incorporated in an unspecified year and is part of the Tata Group. The latest quarterly results reported are for March 2026, showing net sales and profit figures.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 3,438 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: -2,132 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 19,211 Cr (Small Cap)<BR><BR>Key Metrics:<BR>P/E: 490.00 <BR>Industry P/E: 93 <BR>Dividend Yield: 1.50% <BR>Debt Equity: 0.32 <BR>Return on Equity: 0.18% <BR>Price to Book: 0.88 <BR><BR>Contact Details:<BR>Address: Bombay House, 24 Homi Mody Street Fort Mumbai Maharashtra : 400001 <BR>Tel: 91-22-66658282 <BR>Email: investors@tatachemicals.com <BR>Website: http://www.tatachemicals.com

View full answer

Are Tata Chemicals Ltd. latest results good or bad?

05-May-2026

Tata Chemicals Ltd.'s latest Q4 FY26 results are poor, showing a net profit loss of ₹2,132 crores, a 3,707.14% decline year-on-year, and a decrease in net sales by 2.02%. The company faces significant operational challenges, indicating an unfavorable outlook.

Tata Chemicals Ltd.'s latest results for Q4 FY26 indicate a challenging financial situation. The company reported a consolidated net profit loss of ₹2,132 crores, which marks a staggering decline of 3,707.14% year-on-year. Additionally, net sales decreased by 2.02% year-on-year to ₹3,438 crores, and the operating margin fell to 7.97%, the lowest level in recent quarters.<BR><BR>The results reveal a significant deterioration in profitability, with the profit after tax margin plummeting to -61.55%. This quarter's performance is particularly alarming due to a sharp sequential decline, with the consolidated loss widening by 2,192.47% compared to the previous quarter.<BR><BR>Overall, the financial metrics reflect severe operational challenges, including declining revenues and margin compression, which suggest that the company is currently facing a profitability crisis. Given these results, the outlook for Tata Chemicals appears unfavorable, and the latest performance can be characterized as poor.

View full answer

When is the next results date for Tata Chemicals Ltd.?

23-Apr-2026

The next results date for Tata Chemicals Ltd. is 04 May 2026.

The next results date for Tata Chemicals Ltd. is scheduled for 04 May 2026.

View full answer

Is Tata Chemicals technically bullish or bearish?

29-Nov-2025

As of November 28, 2025, Tata Chemicals exhibits a strong bearish trend, supported by multiple indicators including bearish MACD, Bollinger Bands, and moving averages across weekly and monthly time frames.

As of 28 November 2025, the technical trend for Tata Chemicals has changed from mildly bearish to bearish. The current stance is bearish with a strong indication from multiple indicators. The MACD is bearish on both the weekly and monthly time frames, and Bollinger Bands also reflect a bearish outlook in both time frames. Daily moving averages confirm a bearish trend, while the KST is bearish on both weekly and monthly levels. Dow Theory indicates a mildly bearish stance on the weekly and monthly charts, and the OBV is also mildly bearish. Overall, the combination of these indicators suggests a strong bearish sentiment for Tata Chemicals.

View full answer

Is Tata Chemicals overvalued or undervalued?

07-Nov-2025

As of November 6, 2025, Tata Chemicals is considered overvalued due to its high PE ratio of 60.22 and poor stock performance, significantly underperforming the Sensex with a return of -24.10%.

As of 6 November 2025, Tata Chemicals' valuation grade has moved from fair to expensive, indicating a shift towards overvaluation. The company is currently assessed as overvalued based on its high PE ratio of 60.22, an EV to EBIT of 38.86, and a notably low Price to Book Value of 0.10. These ratios suggest that the market is pricing the stock at a premium compared to its underlying fundamentals.<BR><BR>In comparison to its peers, Tata Chemicals stands out with a significantly higher PE ratio than Adani Enterprises, which has a PE of 127.79, and is also more expensive than DCM Shriram, which is valued attractively with a PE of 26.89. Furthermore, Tata Chemicals has underperformed the Sensex significantly over the past year, with a stock return of -24.10% compared to the Sensex's 3.65% return. Overall, the data supports the conclusion that Tata Chemicals is overvalued in the current market environment.

View full answer

How has been the historical performance of Tata Chemicals?

01-Nov-2025

Tata Chemicals has shown a declining trend in net sales and profitability, with net sales dropping from 16,789 Cr in Mar'23 to 14,887 Cr in Mar'25, and profit after tax decreasing from 381 Cr to 200 Cr in the same period. The company's operating profit margin also fell significantly, indicating reduced operational efficiency.

Answer:<BR>The historical performance of Tata Chemicals shows a fluctuating trend in net sales and profitability over the years, with a notable decline in recent periods.<BR><BR>Breakdown:<BR>Tata Chemicals reported net sales of 14,887.00 Cr in Mar'25, down from 15,421.00 Cr in Mar'24 and 16,789.00 Cr in Mar'23, indicating a downward trend from a peak in Mar'23. The total operating income followed a similar pattern, with a decrease to 14,887.00 Cr in Mar'25 from 15,421.00 Cr in Mar'24. Operating profit (PBDIT) also decreased significantly to 2,178.00 Cr in Mar'25 from 3,133.00 Cr in Mar'24 and 4,040.00 Cr in Mar'23, reflecting a decline in operational efficiency, as evidenced by the operating profit margin dropping to 13.12% in Mar'25 from 18.46% in Mar'24. Profit before tax fell sharply to 367.00 Cr in Mar'25 from 762.00 Cr in Mar'24, and profit after tax decreased to 200.00 Cr from 381.00 Cr in the same period. The consolidated net profit also declined to 235.00 Cr in Mar'25 from 268.00 Cr in Mar'24, contrasting sharply with the high of 2,317.00 Cr in Mar'23. On the balance sheet, total assets increased to 37,750.00 Cr in Mar'25 from 36,711.00 Cr in Mar'24, while total liabilities also rose to 37,750.00 Cr from 36,711.00 Cr, indicating a consistent leverage level. Cash flow from operating activities decreased to 1,761.00 Cr in Mar'25 from 3,016.00 Cr in Mar'24, contributing to a net cash inflow of 123.00 Cr, a recovery from a net outflow of -83.00 Cr in Mar'24. Overall, Tata Chemicals has experienced significant fluctuations in its financial performance, particularly in profitability and cash flow, over the past few years.

View full answer

Who are the top shareholders of the Tata Chemicals?

17-Jul-2025

The top shareholders of Tata Chemicals include Tata Sons Private Limited with 31.9%, mutual funds with 9.15%, foreign institutional investors at 13.3%, and individual investors holding 22.92%. There are no pledged promoter holdings, and the Life Insurance Corporation of India - P & Gs Fund is the largest public shareholder with a minimal stake.

The top shareholders of Tata Chemicals include the promoters, with Tata Sons Private Limited holding the largest share at 31.9%. Additionally, mutual funds collectively hold 9.15% through 40 different schemes, while foreign institutional investors (FIIs) own 13.3% across 155 entities. Individual investors account for 22.92% of the holdings. Notably, there are no pledged promoter holdings, and the highest public shareholder is the Life Insurance Corporation of India - P & Gs Fund, which holds a minimal stake.

View full answer

Has Tata Chemicals declared dividend?

06-Jun-2025

Yes, Tata Chemicals has declared a dividend of 110% (₹15 per share) with an ex-date of June 12, 2024. While the dividend yield is 1.61%, total returns over shorter periods have been negative, despite positive long-term performance.

Tata Chemicals Ltd. has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 110%<BR>- Amount per share: 15<BR>- Ex-date: 12 Jun 2024<BR><BR>Dividend Yield: 1.61%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -16.85%, the dividend return was 0.99%, resulting in a total return of -15.86%.<BR><BR>Over the past year, the price return was -12.38%, the dividend return was 2.34%, leading to a total return of -10.04%.<BR><BR>In the 2-year period, the price return was -6.15%, the dividend return was 2.66%, resulting in a total return of -3.49%.<BR><BR>For the 3-year period, the price return was -1.71%, the dividend return was 5.48%, culminating in a total return of 3.77%.<BR><BR>In the last 4 years, the price return was 24.75%, the dividend return was 7.76%, resulting in a total return of 32.51%.<BR><BR>Over the past 5 years, the price return was 192.35%, the dividend return was 21.34%, leading to a total return of 213.69%.<BR><BR>Overall, Tata Chemicals has declared a significant dividend, but the total returns over shorter periods have been negative, indicating a challenging performance in the near term despite positive long-term returns.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Weak Long Term Fundamental Strength with a -4.01% CAGR growth in Operating Profits over the last 5 years

  • The company has been able to generate a Return on Equity (avg) of 5.13% signifying low profitability per unit of shareholders funds
2

With a fall in PBT of -1939.44%, the company declared Very Negative results in Mar 26

3

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Commodity Chemicals

stock-summary
Market cap

INR 18,534 Cr (Small Cap)

stock-summary
P/E

496.00

stock-summary
Industry P/E

94

stock-summary
Dividend Yield

1.51%

stock-summary
Debt Equity

0.32

stock-summary
Return on Equity

0.18%

stock-summary
Price to Book

0.88

Revenue and Profits:
Net Sales:
3,438 Cr
(Quarterly Results - Mar 2026)
Net Profit:
-2,132 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (1.51%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
19.46%
1.82%
21.28%
6 Months
-4.94%
1.44%
-3.5%
1 Year
-20.31%
1.17%
-19.14%
2 Years
-34.06%
1.99%
-32.07%
3 Years
-25.78%
3.71%
-22.07%
4 Years
-9.93%
6.38%
-3.55%
5 Years
3.08%
8.82%
11.9%

Latest dividend: 11.001528096131139 per share ex-dividend date: Jun-10-2026

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Announcements stock-summary

Closure of Trading Window

22-Jun-2026 | Source : BSE

Intimation of closure of trading window

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

13-Jun-2026 | Source : BSE

Intimation of Schedule of Analysts/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015

Announcement under Regulation 30 (LODR)-Newspaper Publication

05-Jun-2026 | Source : BSE

Please find enclosed copy of Newspaper Advertisement -Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Tata Chemicals Ltd. has declared 110% dividend, ex-date: 10 Jun 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
7.41%
EBIT Growth (5y)
-4.01%
EBIT to Interest (avg)
3.64
Debt to EBITDA (avg)
2.90
Net Debt to Equity (avg)
0.32
Sales to Capital Employed (avg)
0.54
Tax Ratio
17.55%
Dividend Payout Ratio
-14.79%
Pledged Shares
0
Institutional Holding
34.77%
ROCE (avg)
6.36%
ROE (avg)
5.13%

Valuation key factors

Factor
Value
P/E Ratio
496
Industry P/E
94
Price to Book Value
0.88
EV to EBIT
42.06
EV to EBITDA
14.08
EV to Capital Employed
0.91
EV to Sales
1.74
PEG Ratio
NA
Dividend Yield
1.51%
ROCE (Latest)
2.15%
ROE (Latest)
0.18%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 34 Schemes (10.64%)

FIIs

Held by 156 FIIs (11.9%)

Promoter with highest holding

Tata Sons Private Limited (31.9%)

Highest Public shareholder

Life Insurance Corporation Of India - P & Gs Fund (9.24%)

Individual Investors Holdings

23.38%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -3.15% vs -8.43% in Dec 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -2,192.47% vs -220.78% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,438.00",
          "val2": "3,550.00",
          "chgp": "-3.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "274.00",
          "val2": "345.00",
          "chgp": "-20.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "153.00",
          "val2": "146.00",
          "chgp": "4.79%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1,837.00",
          "val2": "-54.00",
          "chgp": "-3,301.85%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2,132.00",
          "val2": "-93.00",
          "chgp": "-2,192.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.97%",
          "val2": "9.72%",
          "chgp": "-1.75%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is -2.47% vs -5.21% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -4.36% vs -64.17% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7,596.00",
          "val2": "7,788.00",
          "chgp": "-2.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,186.00",
          "val2": "1,192.00",
          "chgp": "-0.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "291.00",
          "val2": "278.00",
          "chgp": "4.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-65.00",
          "val2": "15.00",
          "chgp": "-533.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "329.00",
          "val2": "344.00",
          "chgp": "-4.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.61%",
          "val2": "15.31%",
          "chgp": "0.30%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -2.04% vs -4.75% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -18.90% vs -73.97% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "11,146.00",
          "val2": "11,378.00",
          "chgp": "-2.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,531.00",
          "val2": "1,626.00",
          "chgp": "-5.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "437.00",
          "val2": "426.00",
          "chgp": "2.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-119.00",
          "val2": "-55.00",
          "chgp": "-116.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "236.00",
          "val2": "291.00",
          "chgp": "-18.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.74%",
          "val2": "14.29%",
          "chgp": "-0.55%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is -2.04% vs -3.46% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is -906.81% vs -12.31% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "14,584.00",
          "val2": "14,887.00",
          "chgp": "-2.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,805.00",
          "val2": "1,953.00",
          "chgp": "-7.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "590.00",
          "val2": "563.00",
          "chgp": "4.80%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1,956.00",
          "val2": "-92.00",
          "chgp": "-2,026.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1,896.00",
          "val2": "235.00",
          "chgp": "-906.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.38%",
          "val2": "13.12%",
          "chgp": "-0.74%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQstock-summary

Mar'26
Dec'25
Change(%)
Net Sales
3,438.00
3,550.00
-3.15%
Operating Profit (PBDIT) excl Other Income
274.00
345.00
-20.58%
Interest
153.00
146.00
4.79%
Exceptional Items
-1,837.00
-54.00
-3,301.85%
Consolidate Net Profit
-2,132.00
-93.00
-2,192.47%
Operating Profit Margin (Excl OI)
7.97%
9.72%
-1.75%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2026 is -3.15% vs -8.43% in Dec 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is -2,192.47% vs -220.78% in Dec 2025

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
7,596.00
7,788.00
-2.47%
Operating Profit (PBDIT) excl Other Income
1,186.00
1,192.00
-0.50%
Interest
291.00
278.00
4.68%
Exceptional Items
-65.00
15.00
-533.33%
Consolidate Net Profit
329.00
344.00
-4.36%
Operating Profit Margin (Excl OI)
15.61%
15.31%
0.30%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is -2.47% vs -5.21% in Sep 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is -4.36% vs -64.17% in Sep 2024

Nine Monthly Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
11,146.00
11,378.00
-2.04%
Operating Profit (PBDIT) excl Other Income
1,531.00
1,626.00
-5.84%
Interest
437.00
426.00
2.58%
Exceptional Items
-119.00
-55.00
-116.36%
Consolidate Net Profit
236.00
291.00
-18.90%
Operating Profit Margin (Excl OI)
13.74%
14.29%
-0.55%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is -2.04% vs -4.75% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2025 is -18.90% vs -73.97% in Dec 2024

Annual Results Snapshot (Consolidated) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
14,584.00
14,887.00
-2.04%
Operating Profit (PBDIT) excl Other Income
1,805.00
1,953.00
-7.58%
Interest
590.00
563.00
4.80%
Exceptional Items
-1,956.00
-92.00
-2,026.09%
Consolidate Net Profit
-1,896.00
235.00
-906.81%
Operating Profit Margin (Excl OI)
12.38%
13.12%
-0.74%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is -2.04% vs -3.46% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2026 is -906.81% vs -12.31% in Mar 2025

stock-summaryCompany CV
About Tata Chemicals Ltd. stock-summary
stock-summary
Tata Chemicals Ltd.
Small Cap
Commodity Chemicals
Tata Chemicals Limited (TCL) is a science-led sustainable chemistry solutions Company and is a part of the Tata Group. The Company operates through two verticals, Basic Chemistry (Alkali Chemicals-soda ash, sodium bicarb, salt, silica & other halogen chemicals) and Specialty Products (specialty silica, prebiotics & formulations, agrochemicals and seeds). It is a global player in soda ash and sodium bicarbonate with manufacturing facilities in India, US, UK and Kenya.
Company Coordinates stock-summary
Company Details
Bombay House, 24 Homi Mody Street Fort Mumbai Maharashtra : 400001
stock-summary
Tel: 91-22-66658282
stock-summary
investors@tatachemicals.com
Registrar Details
TSR Darashaw Ltd, 6-10 , Haji Moosa Patrawala Indl. Est , 20 Dr.E.Moses Road , Mahalaxmi , Mumbai